Ticker Symbol: SUDFF
Arovella Therapeutics Ltd
Exchange: US OTC
Country:
AU
Currency:
USD
Asset
Type: Common Stock
Company Profile
Suda Pharmaceuticals Ltd. develops pharmaceuticals and distributes medical devices and consumables. Its activities include pharmaceutical development of drug delivery technology and medical devices and consumables distribution. The company operates through following business segment: Suda; and Malaria Research Company. The Suda segment includes research and development to create new human pharmaceutical products by combining proven drugs with innovated, patented, delivery technologies. The Malaria Research Company segment segment is the pharmaceutical development segment for the treatment of malaria. Suda Pharmaceuticals was founded on December 21, 1999 and is headquartered in Osborne Park, Australia.
Sector: Health Technology
Industry: Pharmaceuticals: Major
Standard Industrial Classification Code (SIC code): 2834
Address: 55 Howe Street
Website: http://www.sudapharma.com
CEO: Michael Baker
Tags:
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: - - -
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 480920880
Valuation
Market Cap: -
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A